Tag : Zepbounds

Will Zepbound’s growth live up to the hype?

adminFffFF0or31rFebruary 5, 2025

by adminFffFF0or31rFebruary 5, 2025021

Investors are hoping to hit the reset button with Eli Lilly ‘s earnings report on Thursday morning. In mid-January, the maker of obesity medication Zepbound...

Tag : Zepbounds

Will Zepbound’s growth live up to the hype?

ECB's Nagel: The inflation numbers I've seen...

Atlanta Fed GDPNow -2.8% vs -1.8% prior

EU floats concessions to White House but...

Dividend stocks to play longevity’s ‘transformational’ opportunity:...

Three reasons why trade tensions between Canada...

Stocks getting hammered . NASDAQ index down...

Bakers Hughes oil rig count -2 at...

Vance on Greenland: Denmark has not done...

ECB's Nagel: The inflation numbers I've seen recently are...

Atlanta Fed GDPNow -2.8% vs -1.8%...

EU floats concessions to White House...

Dividend stocks to play longevity’s ‘transformational’...

Three reasons why trade tensions between...

Stocks getting hammered . NASDAQ index...

Bakers Hughes oil rig count -2...

Featured News

ECB's Nagel: The inflation numbers I've seen recently are encouraging

Atlanta Fed GDPNow -2.8% vs -1.8% prior

EU floats concessions to White House but expects 10-25% tariff rate

Dividend stocks to play longevity’s ‘transformational’ opportunity: UBS

Guide & Analytics

ECB's Nagel: The inflation numbers I've seen recently are encouraging

Atlanta Fed GDPNow -2.8% vs -1.8% prior

EU floats concessions to White House but expects 10-25% tariff rate

Dividend stocks to play longevity’s ‘transformational’ opportunity: UBS

Recent Posts

ECB's Nagel: The inflation numbers I've seen recently are encouraging

Atlanta Fed GDPNow -2.8% vs -1.8% prior

EU floats concessions to White House but expects 10-25% tariff rate

Dividend stocks to play longevity’s ‘transformational’ opportunity: UBS

Newsletter

Categories